Ethyl 5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylate

Catalog No.: 
ACQDDR768
CAS No.: 
1697188-73-0
Molecular Formula: 
C10H11N3O2
Molecular Weight: 
205.22
Ethyl 5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$143.00InquiryInquiry
1g95%$415.00InquiryInquiry
5g95%$2034.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylate
IUPAC Nameethyl 5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylate
Molecular FormulaC10H11N3O2
Molecular Weight205.22
SMILESCC1=NC2=CC(C(OCC)=O)=NN2C=C1
InChI KeyIAVLOSRHPFYTAH-UHFFFAOYSA-N
SynonymPyrazolo[1,5-a]pyrimidine-2-carboxylic acid, 5-methyl-, ethyl ester;Ethyl 5-methylpyrazolo1,5-apyrimidin-2-carboxylate;Ethyl 5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylate
CAS No.1697188-73-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQDDR768 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVUCD356 route compound structure diagram
    ACVUCD3561363405-21-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQDDR768 route product structure diagram
    ACQDDR7681697188-73-0
Inquiry

2. ACQDDR768 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQDDR768 route product structure diagram
    ACQDDR7681697188-73-0
Inquiry

3. ACQDDR768 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQDDR768 route product structure diagram
    ACQDDR7681697188-73-0
Inquiry

Comments (0)